ClinicalTrials.gg
Active, not recruitingNCT03187366Updated Mar 22, 2023

Schistosomiasis in Senegal

An interventional study of Bottom-up intervention in Schistosomiasis, sponsored by University of Notre Dame. Active, not recruiting at 1 site in Senegal. Open to participants aged 5 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-22.

Sponsored by University of Notre Dame · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 2 months ago, but the record still lists the study as active, not recruiting.
  • Registered 5 months after the study started (first participant enrolled Jan 2017, registered Jun 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
1,477
Allocation
Randomized
Ages
5 Years to 17 Years
Sex
All
01

Study summary

Schistosomiasis is a flatworm transmitted from freshwater snails to humans in the tropics. In addition to this infectious disease, tropical developing countries are faced with malnutrition. We propose to alter pesticide and compost use to reduce schistosomiasis and maintain or even improve crop production.

Read the detailed description

We propose two types of manipulations. Bottom-up manipulations will affect snail resources, whereas top-down manipulations will affect snail predators. For the bottom-up manipulations, we will clear schistosoma infections in school children, then remove the primary habitat for snails, the submerged macrophyte Ceratophyllum demersum (with proper unmanipulated controls), compost it, apply it to crops, and then quantify reinfection rates and crop yields. The second bottom-up manipulation will be to clear schistosoma infections in school children, apply three agrochemical treatments (status quo control, shift to lower risk herbicides, or eliminate herbicides and fertilizers), and then quantify reinfection rates and crop yields. Farmers will be compensated for any loss in yields. For the top-down manipulations, every village will receive prawns that depredate snails. We will clear schistosoma infections in school children, apply three agrochemical treatments (status quo control, shift to lower risk insecticides that don't kill prawns, or eliminate insecticides), and then quantify reinfection rates and crop yields. Farmers will be compensated for any loss in yields.

02

Conditions studied

  • Schistosomiasis

Browse trials for

03

In context

Schistosomiasis

79 studies on the registry are indexed under Schistosomiasis; 14 are open to participants now.

This study's enrollment of 1,477 is above the median of 289 across 52 interventional studies indexed under Schistosomiasis.

Browse Schistosomiasis studies →

Lead sponsor

University of Notre Dame is the lead sponsor of 29 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • School age children

Exclusion criteria

Exclusion Criteria:

  • Non-school age children
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,477 participants (actual)

Study arms

  • No intervention
    Status quo

    Status quo pesticide use

  • Active comparator
    Low risk

    Villages shifted to low risk pesticides that don't kill prawns

    Other: Bottom-up intervention

  • Experimental
    No agrochemicals

    Villages that eliminate agrochemicals

    Other: Bottom-up intervention

Interventions

  • OtherBottom-up intervention

    Some interventions are bottom-up, where we manipulate the resources of snails and some are top-down, where we manipulate the predators of snails.

    Also known as: Top-down intervention

06

What researchers measure

Primary outcomes

  1. Schistosomiasis reinfection rate

    Schistosomiasis reinfection rate

    Time frame: One year

Secondary outcomes

  1. Crop yields

    Crop yields

    Time frame: One year

07

Study locations

1 site
  • Espoir Pour La Santé (EPLS)
    Saint-Louis, Senegal
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2017 (actual). Primary completion is estimated for Sep 2025, 104 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 12, 2017
First posted
Jun 14, 2017
StartActual
Jan 2, 2017
Primary completionEst.
Sep 2025
CompletionEst.
Sep 2025
Last update
Mar 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03187366
Lead sponsor
University of Notre Dame
Collaborators
Biomedical Research Center EPLS
Responsible party
Sponsor
First posted
Jun 14, 2017
Start date
Jan 2, 2017
Primary completion
Sep 2025 (estimated)
Completion
Sep 2025 (estimated)
Last update
Mar 22, 2023

Study contacts

Jason R Rohr, PhD
principal investigator · University of South Florida, Department of Integrative Biology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion